Envisagenics, Inc., a New York-based biotechnology company leveraging artificial intelligence (AI) and RNA-splicing analytics for discovery and development of disease specific therapeutics, announced today...
Read More »Envisagenics wins SBIR grant for continued development of SpliceCore RNA-Seq analysis software
Envisagenics, Inc., a New York based biotechnology company, announced today that it was awarded a Small Business Innovation Research (SBIR) Phase II grant from the National Institutes of Health (NIH). This grant will provide $1.5 million over two years for Envisagenics’ ...
Read More »Cell Microsystems Continues Momentum with $1.5M NIH Grant for Innovative Single-Cell RNA-Seq Platform
Cell Microsystems, a provider of innovative tools and scalable solutions for the sorting and isolation of single cells, announced today it has been awarded a $1.5 million grant under the National Institutes of Health (NIH) SBIR program. The proposed system ...
Read More »SomaGenics Awarded NIH Funding to Develop NGS Single-Cell Analysis of Small RNAs
SomaGenics announced the receipt of a Phase I SBIR grant from the NIH to develop RealSeq®-SC (Single Cell), expected to be the first commercially available library preparation kit for profiling small RNAs (including microRNAs) from single cells using NGS methods. ...
Read More »SeqLL Awarded SBIR to Advance the Development of Direct RNA Sequencing (DRS™) Technology
SeqLL, LLC announced today that it has been awarded a Phase I SBIR grant in the amount of $223,465 by the NIH/National Human Genome Research Institute to advance the development of Direct RNA Sequencing (DRS™) technology on SeqLL’s True Single ...
Read More »Bioo Scientific awarded two SBIR grants to enable the improvement of single cell sequencing technologies
Bioo Scientific is developing tools which will allow researchers to study dynamic variation in epigenomics from a single cell. Until now, single-cell analysis of DNA methylation has proven itself to be technically challenging and there are no kits commercially available ...
Read More »